Atrial fibrillation risk and stroke prevention study
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at people who are at high risk for atrial fibrillation (an irregular heartbeat) to understand their risk of stroke and blood clots. You may be able to join if you are 65-95 years old, have no prior atrial fibrillation, and can use a smartphone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 65 and 95 years old.
- You have never been diagnosed with atrial fibrillation or stroke.
- You are at high risk for atrial fibrillation based on a special risk score that uses your sex, age, weight, heart rate, and other health conditions.
- You have a CHA2DS2-VASc score of 2 or higher (this measures your stroke risk based on factors like high blood pressure, diabetes, and age).
- You can use a smartphone (or have a caregiver who can).
- You are not currently taking blood thinners (anticoagulants) and do not have a pacemaker.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a registry that collects real-world information on people with atrial fibrillation to learn more about their health and treatment. It's for adults aged 18 to 64 with a low stroke risk score who can come for checkups.
This trial tests whether using an artificial intelligence (AI) system to read your electrocardiogram (ECG, a heart rhythm test) can better evaluate your heart's structure and function, helping manage atrial fibrillation (AF). You may qualify if you have AF and need an echocardiogram (ultrasound of the heart).
This study is testing if an AI program can help doctors choose better treatments for atrial fibrillation (AF). It is for people who were recently diagnosed with AF and have noticeable symptoms.
This trial is testing a new approach to care for older adults with atrial fibrillation (an irregular heartbeat) who also have other health conditions. It aims to see if a more integrated, team-based care plan helps improve their overall health and quality of life.
This study tests a new approach for people with atrial fibrillation (a type of irregular heartbeat) who are also at high risk for stroke. It combines a procedure to fix the heart's electrical signals with closing off a small pouch in the heart to reduce stroke risk, potentially avoiding long-term blood thinners.
This trial uses a special long-term heart monitor (one wire) that uses artificial intelligence to find new cases of atrial fibrillation, a type of irregular heartbeat that can increase stroke risk. If you're 60 or older and haven't had AF before, this study could help catch it early.
Hear when a new MACE trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.